Skip to content
MamaGLP — home

Mama-Match

Rank #27 for first-timers · Grade C

Strut Health review

$149/mo injectable semaglutide, $99/mo oral lozenge, $325/mo tirzepatide ($199 on auto-refill) — with a February 2026 FDA warning letter you should read first.

$149/mo
Consult Medication
Meet Strut Health
  • HSA / FSA eligible
  • Independently scored
  • No insurance needed

Referral link, separate from the score

Written by Camila Rael, editora mom, not a clinician treating youReviewed

Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.

Strut Health at a glance

Semaglutide
$149/mo (injectable) · $99/mo (oral lozenge)
Tirzepatide
$325/mo standard ($199/mo on auto-refill)
Coverage
Not published (confirm at signup)
Brand-name
Compounded only

How we scored Strut Health

Each factor is judged from Strut Health's actual pricing, disclosures and support, then combined into the Mama-Match Score of 77/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.

Gentle, easy start82/100 · Solid

A reasonable intake, though a little more standard than hand-held.

Honest, upfront pricing74/100 · Fair

The cost is unpredictable, hidden behind a quiz, or in the premium range.

Real clinician support72/100 · Weak

Little public detail about who oversees your care, and how.

Available nationwide76/100 · Fair

Coverage is limited or gated behind a signup.

Ongoing help & check-ins74/100 · Fair

Support is thin once the prescription ships.

Simple, fair cancellation80/100 · Solid

Cancellation is manageable but not frictionless.

How we verified this review

Last reviewed
July 2026
Confidence
Medium
Primary sources

Company website and regulatory records

$149 for the injectable and $99 for the oral tablet, with tirzepatide at $325 or $199 on auto-refill — all of them 'from' rates. Strut received an FDA warning letter in February 2026 over claims implying FDA approval of its compounded products. It doesn't publish the states it serves.

Another option to compare

Visit Found Health

We may earn a commission if you sign up through this link.

Pricing

Prices re-verified

MedicationPricePlan
Oral semaglutide$99Sublingual oral tablet (auto-refill)A 'from' rate with auto-refill; the standard price without a recurring plan isn't fully published.
Compounded semaglutide$149Injectable (auto-refill)A 'from' rate with auto-refill.
Compounded tirzepatide$199 → $325Injectable$325/mo standard; from $199/mo with auto-refill. Restricted to patients who don't respond to or can't use other GLP-1s.
Oral tirzepatide$199 → $239Oral tirzepatide lozenge (30-day)$239 for a 30-day supply, or as low as $199/mo on auto-refill (17% off). Needle-free lozenge.

Swipe the table to see plan details →

HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what Strut Health disclosed publicly at our last review and change often; confirm the current number on Strut Health's site.

What we like

  • A genuine oral/sublingual semaglutide option, plus injectable semaglutide and tirzepatide
  • Low headline pricing with auto-refill (from ~$99/mo on oral)
  • Simple asynchronous questionnaire signup with cancel-anytime language

The caveats

  • February 2026 FDA warning letter for implying FDA approval of compounded GLP-1s
  • The cheap prices are auto-refill (recurring) rates; the standard tiers aren't fully published
  • Tirzepatide is gated behind medical-necessity language
  • The states it serves aren't published; no named pharmacy or medical director; no postpartum focus

Strut Health for moms: our verdict

$149/mo injectable semaglutide, $99/mo oral lozenge, $325/mo tirzepatide ($199 on auto-refill) — with a February 2026 FDA warning letter you should read first. It runs about $149/mo — toward the affordable end of what we track.

We looked at Strut Health the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Strut Health actually costs

  • Oral semaglutide — Sublingual oral tablet (auto-refill): $99/mo
  • Compounded semaglutide — Injectable (auto-refill): $149/mo
  • Compounded tirzepatide — Injectable: $199 to start, then $325/mo
  • Oral tirzepatide — Oral tirzepatide lozenge (30-day): $199 to start, then $239/mo

That lands below the median ongoing price of about $179 across the providers we track for moms — a real cost advantage.

That price covers the consult and the medication.

The medications Strut Health prescribes

Strut Health lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Strut Health lists its coverage as: Not published (confirm at signup).

Where Strut Health fits — and where it doesn't — for moms

A good fit if…

  • the monthly cost is a real barrier and you want a low, predictable number.
  • you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

  • you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
  • a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
  • you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Strut Health, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Strut Health is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.

The bottom line

Best for: Listed for transparency — read the FDA warning and the auto-refill pricing terms before choosing it over a provider with a cleaner record.

Other gentle first steps

Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.

  • Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.

    Meet CoreAge Rx
  • $199/mo semaglutide, $299/mo tirzepatide month-to-month, with coaching, unlimited follow-ups and a full Spanish site in 49 states — and a two-month minimum you cannot cancel out of.

    Meet ShedRx
  • $299/mo semaglutide, $349/mo tirzepatide ongoing, flat across doses — but it advertises brand medications it cannot sell and carries an open FDA warning letter.

    Meet Sprout Health

Keep comparing Strut Health

Strut Health, answered

Does Strut Health have an FDA warning letter?
Yes, and we're not going to hide it: in February 2026 the FDA issued Strut a warning letter (reference 721448) for marketing its compounded semaglutide and tirzepatide in ways that implied FDA approval. That's a real regulatory flag. It doesn't make the medication unavailable, but for a mom just starting out, a clean regulatory record is a reasonable thing to prioritize — and a reason we'd point you toward a provider without one first.
Does Strut offer a needle-free option?
Yes — Strut is one of the few here with a sublingual (under-the-tongue) oral semaglutide tablet, advertised from $99/mo with auto-refill, alongside injectable semaglutide (~$149) and tirzepatide (~$199 with auto-refill). Just calibrate your expectations: sublingual delivery of these peptides is far less studied than the injections used in the trials, so treat it as a convenience option, not a proven equal.
Why are Strut's prices 'from' prices?
Those headline numbers are the auto-refill (recurring) rates — the standard tiers, without a recurring plan, aren't fully published, so the cheap price assumes you stay enrolled. Tirzepatide also carries medical-necessity language (offered to patients who don't respond to or can't use other GLP-1s). Confirm the exact ongoing price and terms in writing before you commit.
Is it safe to use Strut while I'm breastfeeding?
Evidence is insufficient to establish that a GLP-1 is safe during breastfeeding. Labels differ by formulation: Wegovy tablets advise against breastfeeding because of the absorption ingredient SNAC; Wegovy injection and Zepbound labeling ask clinicians to weigh maternal need, breastfeeding benefits and possible infant risks. This does not establish that injections are safe. Discuss the exact medication and the program's eligibility policy with your clinician and your baby's pediatrician before deciding; our GLP-1 and breastfeeding guide explains the distinction.

Prices, states and verification reflect what Strut Health disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.

← Back to all providers